nodes	percent_of_prediction	percent_of_DWPC	metapath
Meprobamate—ABCB1—Ethinyl Estradiol—osteoporosis	0.0829	0.24	CbGbCtD
Meprobamate—CYP2C19—Cholecalciferol—osteoporosis	0.0822	0.238	CbGbCtD
Meprobamate—CYP2C19—Estradiol—osteoporosis	0.0662	0.192	CbGbCtD
Meprobamate—ABCB1—Conjugated Estrogens—osteoporosis	0.0609	0.176	CbGbCtD
Meprobamate—ABCB1—Estradiol—osteoporosis	0.0534	0.155	CbGbCtD
Meprobamate—Ecchymosis—Risedronate—osteoporosis	0.00587	0.00898	CcSEcCtD
Meprobamate—Dermatitis bullous—Calcitriol—osteoporosis	0.00586	0.00896	CcSEcCtD
Meprobamate—Syncope—Calcium Acetate—osteoporosis	0.00567	0.00867	CcSEcCtD
Meprobamate—Loss of consciousness—Calcium Acetate—osteoporosis	0.00556	0.0085	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Etidronic acid—osteoporosis	0.00527	0.00805	CcSEcCtD
Meprobamate—Shock—Calcium Acetate—osteoporosis	0.00508	0.00776	CcSEcCtD
Meprobamate—Agranulocytosis—Etidronic acid—osteoporosis	0.00496	0.00758	CcSEcCtD
Meprobamate—Bronchospasm—Ibandronate—osteoporosis	0.00486	0.00743	CcSEcCtD
Meprobamate—Hypotension—Calcium Acetate—osteoporosis	0.00482	0.00737	CcSEcCtD
Meprobamate—Paraesthesia—Calcium Acetate—osteoporosis	0.00464	0.00709	CcSEcCtD
Meprobamate—Dysarthria—Estradiol—osteoporosis	0.0046	0.00702	CcSEcCtD
Meprobamate—Erythema multiforme—Etidronic acid—osteoporosis	0.00451	0.00689	CcSEcCtD
Meprobamate—Stevens-Johnson syndrome—Alendronate—osteoporosis	0.00449	0.00686	CcSEcCtD
Meprobamate—Stomatitis—Alendronate—osteoporosis	0.00441	0.00675	CcSEcCtD
Meprobamate—Drowsiness—Calcitriol—osteoporosis	0.00432	0.0066	CcSEcCtD
Meprobamate—Stomatitis—Ibandronate—osteoporosis	0.0043	0.00657	CcSEcCtD
Meprobamate—Dermatitis bullous—Conjugated Estrogens—osteoporosis	0.00412	0.0063	CcSEcCtD
Meprobamate—Purpura—Conjugated Estrogens—osteoporosis	0.00409	0.00625	CcSEcCtD
Meprobamate—Oedema peripheral—Estropipate—osteoporosis	0.00407	0.00621	CcSEcCtD
Meprobamate—Oedema peripheral—Alendronate—osteoporosis	0.004	0.00612	CcSEcCtD
Meprobamate—Oedema peripheral—Raloxifene—osteoporosis	0.00394	0.00602	CcSEcCtD
Meprobamate—Erythema multiforme—Estropipate—osteoporosis	0.0039	0.00596	CcSEcCtD
Meprobamate—Oedema peripheral—Ibandronate—osteoporosis	0.0039	0.00596	CcSEcCtD
Meprobamate—Erythema multiforme—Alendronate—osteoporosis	0.00384	0.00587	CcSEcCtD
Meprobamate—Bronchospasm—Pamidronate—osteoporosis	0.00381	0.00582	CcSEcCtD
Meprobamate—Hypersensitivity—Calcium Acetate—osteoporosis	0.0038	0.00581	CcSEcCtD
Meprobamate—Angioedema—Etidronic acid—osteoporosis	0.00379	0.0058	CcSEcCtD
Meprobamate—Leukopenia—Etidronic acid—osteoporosis	0.00372	0.00568	CcSEcCtD
Meprobamate—Asthenia—Calcium Acetate—osteoporosis	0.0037	0.00566	CcSEcCtD
Meprobamate—Lymphadenopathy—Estradiol—osteoporosis	0.0037	0.00565	CcSEcCtD
Meprobamate—Erythema multiforme—Calcitriol—osteoporosis	0.00366	0.0056	CcSEcCtD
Meprobamate—Pruritus—Calcium Acetate—osteoporosis	0.00365	0.00558	CcSEcCtD
Meprobamate—Chills—Ibandronate—osteoporosis	0.00355	0.00543	CcSEcCtD
Meprobamate—Diarrhoea—Calcium Acetate—osteoporosis	0.00353	0.0054	CcSEcCtD
Meprobamate—Vascular purpura—Estradiol—osteoporosis	0.00353	0.00539	CcSEcCtD
Meprobamate—Bronchospasm—Zoledronate—osteoporosis	0.00348	0.00532	CcSEcCtD
Meprobamate—Arrhythmia—Calcitriol—osteoporosis	0.00346	0.00529	CcSEcCtD
Meprobamate—Dizziness—Calcium Acetate—osteoporosis	0.00341	0.00522	CcSEcCtD
Meprobamate—Stomatitis—Pamidronate—osteoporosis	0.00337	0.00515	CcSEcCtD
Meprobamate—Bronchospasm—Conjugated Estrogens—osteoporosis	0.00335	0.00512	CcSEcCtD
Meprobamate—Angioedema—Estropipate—osteoporosis	0.00328	0.00502	CcSEcCtD
Meprobamate—Vomiting—Calcium Acetate—osteoporosis	0.00328	0.00502	CcSEcCtD
Meprobamate—Purpura—Estradiol—osteoporosis	0.00327	0.005	CcSEcCtD
Meprobamate—Asthenia—Ergocalciferol—osteoporosis	0.00327	0.005	CcSEcCtD
Meprobamate—Angioedema—Alendronate—osteoporosis	0.00323	0.00494	CcSEcCtD
Meprobamate—Vertigo—Estropipate—osteoporosis	0.00323	0.00493	CcSEcCtD
Meprobamate—Agranulocytosis—Pamidronate—osteoporosis	0.00322	0.00493	CcSEcCtD
Meprobamate—Oedema peripheral—Risedronate—osteoporosis	0.00321	0.00491	CcSEcCtD
Meprobamate—Vertigo—Alendronate—osteoporosis	0.00318	0.00486	CcSEcCtD
Meprobamate—Palpitations—Estropipate—osteoporosis	0.00317	0.00485	CcSEcCtD
Meprobamate—Erythema multiforme—Ethinyl Estradiol—osteoporosis	0.00316	0.00483	CcSEcCtD
Meprobamate—Angioedema—Ibandronate—osteoporosis	0.00315	0.00481	CcSEcCtD
Meprobamate—Vertigo—Raloxifene—osteoporosis	0.00313	0.00478	CcSEcCtD
Meprobamate—Syncope—Raloxifene—osteoporosis	0.00312	0.00477	CcSEcCtD
Meprobamate—Agitation—Calcitriol—osteoporosis	0.0031	0.00474	CcSEcCtD
Meprobamate—Vertigo—Ibandronate—osteoporosis	0.0031	0.00473	CcSEcCtD
Meprobamate—Stomatitis—Zoledronate—osteoporosis	0.00308	0.0047	CcSEcCtD
Meprobamate—Nausea—Calcium Acetate—osteoporosis	0.00307	0.00469	CcSEcCtD
Meprobamate—Loss of consciousness—Raloxifene—osteoporosis	0.00306	0.00468	CcSEcCtD
Meprobamate—Palpitations—Ibandronate—osteoporosis	0.00304	0.00465	CcSEcCtD
Meprobamate—Paraesthesia—Etidronic acid—osteoporosis	0.00304	0.00465	CcSEcCtD
Meprobamate—Agranulocytosis—Zoledronate—osteoporosis	0.00294	0.0045	CcSEcCtD
Meprobamate—Anaphylactic shock—Estropipate—osteoporosis	0.00293	0.00448	CcSEcCtD
Meprobamate—Arrhythmia—Risedronate—osteoporosis	0.00291	0.00445	CcSEcCtD
Meprobamate—Anaphylactic shock—Ibandronate—osteoporosis	0.00281	0.0043	CcSEcCtD
Meprobamate—Shock—Raloxifene—osteoporosis	0.00279	0.00427	CcSEcCtD
Meprobamate—Oedema peripheral—Zoledronate—osteoporosis	0.00279	0.00426	CcSEcCtD
Meprobamate—Chills—Pamidronate—osteoporosis	0.00278	0.00425	CcSEcCtD
Meprobamate—Shock—Ibandronate—osteoporosis	0.00277	0.00423	CcSEcCtD
Meprobamate—Anaphylactic shock—Calcitriol—osteoporosis	0.00275	0.00421	CcSEcCtD
Meprobamate—Nausea—Ergocalciferol—osteoporosis	0.00271	0.00414	CcSEcCtD
Meprobamate—Oedema peripheral—Conjugated Estrogens—osteoporosis	0.00269	0.00411	CcSEcCtD
Meprobamate—Bronchospasm—Estradiol—osteoporosis	0.00268	0.0041	CcSEcCtD
Meprobamate—Angioedema—Ethinyl Estradiol—osteoporosis	0.00266	0.00407	CcSEcCtD
Meprobamate—Paraesthesia—Estropipate—osteoporosis	0.00263	0.00402	CcSEcCtD
Meprobamate—Somnolence—Estropipate—osteoporosis	0.00261	0.00398	CcSEcCtD
Meprobamate—Angioedema—Risedronate—osteoporosis	0.00259	0.00397	CcSEcCtD
Meprobamate—Erythema multiforme—Conjugated Estrogens—osteoporosis	0.00258	0.00394	CcSEcCtD
Meprobamate—Vertigo—Risedronate—osteoporosis	0.00255	0.0039	CcSEcCtD
Meprobamate—Syncope—Risedronate—osteoporosis	0.00255	0.00389	CcSEcCtD
Meprobamate—Chills—Zoledronate—osteoporosis	0.00254	0.00388	CcSEcCtD
Meprobamate—Arrhythmia—Zoledronate—osteoporosis	0.00253	0.00387	CcSEcCtD
Meprobamate—Paraesthesia—Ibandronate—osteoporosis	0.00252	0.00386	CcSEcCtD
Meprobamate—Hypersensitivity—Etidronic acid—osteoporosis	0.0025	0.00382	CcSEcCtD
Meprobamate—Loss of consciousness—Risedronate—osteoporosis	0.0025	0.00381	CcSEcCtD
Meprobamate—Agitation—Pamidronate—osteoporosis	0.00248	0.00379	CcSEcCtD
Meprobamate—Angioedema—Pamidronate—osteoporosis	0.00247	0.00377	CcSEcCtD
Meprobamate—Somnolence—Calcitriol—osteoporosis	0.00245	0.00374	CcSEcCtD
Meprobamate—Arrhythmia—Conjugated Estrogens—osteoporosis	0.00244	0.00372	CcSEcCtD
Meprobamate—Syncope—Pamidronate—osteoporosis	0.00242	0.0037	CcSEcCtD
Meprobamate—Leukopenia—Pamidronate—osteoporosis	0.00242	0.00369	CcSEcCtD
Meprobamate—Pruritus—Etidronic acid—osteoporosis	0.0024	0.00367	CcSEcCtD
Meprobamate—Loss of consciousness—Pamidronate—osteoporosis	0.00237	0.00363	CcSEcCtD
Meprobamate—Diarrhoea—Etidronic acid—osteoporosis	0.00232	0.00354	CcSEcCtD
Meprobamate—Body temperature increased—Estropipate—osteoporosis	0.00232	0.00354	CcSEcCtD
Meprobamate—Body temperature increased—Alendronate—osteoporosis	0.00228	0.00349	CcSEcCtD
Meprobamate—Shock—Risedronate—osteoporosis	0.00228	0.00348	CcSEcCtD
Meprobamate—Agitation—Zoledronate—osteoporosis	0.00227	0.00346	CcSEcCtD
Meprobamate—Angioedema—Zoledronate—osteoporosis	0.00225	0.00344	CcSEcCtD
Meprobamate—Body temperature increased—Raloxifene—osteoporosis	0.00225	0.00343	CcSEcCtD
Meprobamate—Body temperature increased—Ibandronate—osteoporosis	0.00222	0.0034	CcSEcCtD
Meprobamate—Vertigo—Zoledronate—osteoporosis	0.00222	0.00339	CcSEcCtD
Meprobamate—Syncope—Zoledronate—osteoporosis	0.00221	0.00338	CcSEcCtD
Meprobamate—Leukopenia—Zoledronate—osteoporosis	0.00221	0.00337	CcSEcCtD
Meprobamate—Anaphylactic shock—Pamidronate—osteoporosis	0.0022	0.00337	CcSEcCtD
Meprobamate—Palpitations—Zoledronate—osteoporosis	0.00218	0.00333	CcSEcCtD
Meprobamate—Body temperature increased—Calcitriol—osteoporosis	0.00218	0.00333	CcSEcCtD
Meprobamate—Angioedema—Conjugated Estrogens—osteoporosis	0.00217	0.00332	CcSEcCtD
Meprobamate—Shock—Pamidronate—osteoporosis	0.00217	0.00331	CcSEcCtD
Meprobamate—Loss of consciousness—Zoledronate—osteoporosis	0.00217	0.00331	CcSEcCtD
Meprobamate—Hypersensitivity—Estropipate—osteoporosis	0.00216	0.0033	CcSEcCtD
Meprobamate—Vomiting—Etidronic acid—osteoporosis	0.00216	0.00329	CcSEcCtD
Meprobamate—Oedema peripheral—Estradiol—osteoporosis	0.00215	0.00329	CcSEcCtD
Meprobamate—Tachycardia—Pamidronate—osteoporosis	0.00215	0.00329	CcSEcCtD
Meprobamate—Dermatitis—Etidronic acid—osteoporosis	0.00214	0.00326	CcSEcCtD
Meprobamate—Vertigo—Conjugated Estrogens—osteoporosis	0.00213	0.00326	CcSEcCtD
Meprobamate—Syncope—Conjugated Estrogens—osteoporosis	0.00213	0.00325	CcSEcCtD
Meprobamate—Hypersensitivity—Alendronate—osteoporosis	0.00213	0.00325	CcSEcCtD
Meprobamate—Headache—Etidronic acid—osteoporosis	0.00212	0.00325	CcSEcCtD
Meprobamate—Asthenia—Estropipate—osteoporosis	0.0021	0.00322	CcSEcCtD
Meprobamate—Palpitations—Conjugated Estrogens—osteoporosis	0.0021	0.00321	CcSEcCtD
Meprobamate—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.00209	0.00319	CcSEcCtD
Meprobamate—Paraesthesia—Risedronate—osteoporosis	0.00208	0.00318	CcSEcCtD
Meprobamate—Pruritus—Estropipate—osteoporosis	0.00207	0.00317	CcSEcCtD
Meprobamate—Asthenia—Alendronate—osteoporosis	0.00207	0.00317	CcSEcCtD
Meprobamate—Hypersensitivity—Ibandronate—osteoporosis	0.00207	0.00317	CcSEcCtD
Meprobamate—Erythema multiforme—Estradiol—osteoporosis	0.00206	0.00315	CcSEcCtD
Meprobamate—Hypotension—Pamidronate—osteoporosis	0.00206	0.00315	CcSEcCtD
Meprobamate—Pruritus—Alendronate—osteoporosis	0.00204	0.00312	CcSEcCtD
Meprobamate—Hypersensitivity—Calcitriol—osteoporosis	0.00203	0.0031	CcSEcCtD
Meprobamate—Asthenia—Ibandronate—osteoporosis	0.00202	0.00308	CcSEcCtD
Meprobamate—Nausea—Etidronic acid—osteoporosis	0.00201	0.00308	CcSEcCtD
Meprobamate—Anaphylactic shock—Zoledronate—osteoporosis	0.00201	0.00308	CcSEcCtD
Meprobamate—Diarrhoea—Estropipate—osteoporosis	0.00201	0.00307	CcSEcCtD
Meprobamate—Pruritus—Ibandronate—osteoporosis	0.00199	0.00304	CcSEcCtD
Meprobamate—Shock—Zoledronate—osteoporosis	0.00198	0.00303	CcSEcCtD
Meprobamate—Paraesthesia—Pamidronate—osteoporosis	0.00198	0.00302	CcSEcCtD
Meprobamate—Diarrhoea—Alendronate—osteoporosis	0.00198	0.00302	CcSEcCtD
Meprobamate—Asthenia—Calcitriol—osteoporosis	0.00197	0.00302	CcSEcCtD
Meprobamate—Tachycardia—Zoledronate—osteoporosis	0.00196	0.003	CcSEcCtD
Meprobamate—Chills—Estradiol—osteoporosis	0.00196	0.00299	CcSEcCtD
Meprobamate—Somnolence—Pamidronate—osteoporosis	0.00196	0.00299	CcSEcCtD
Meprobamate—Pruritus—Calcitriol—osteoporosis	0.00195	0.00298	CcSEcCtD
Meprobamate—Diarrhoea—Raloxifene—osteoporosis	0.00194	0.00297	CcSEcCtD
Meprobamate—Dizziness—Estropipate—osteoporosis	0.00194	0.00296	CcSEcCtD
Meprobamate—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.00194	0.00296	CcSEcCtD
Meprobamate—Diarrhoea—Ibandronate—osteoporosis	0.00192	0.00294	CcSEcCtD
Meprobamate—Dizziness—Alendronate—osteoporosis	0.00191	0.00292	CcSEcCtD
Meprobamate—Shock—Conjugated Estrogens—osteoporosis	0.00191	0.00291	CcSEcCtD
Meprobamate—Tachycardia—Conjugated Estrogens—osteoporosis	0.00189	0.00289	CcSEcCtD
Meprobamate—Diarrhoea—Calcitriol—osteoporosis	0.00188	0.00288	CcSEcCtD
Meprobamate—Hypotension—Zoledronate—osteoporosis	0.00188	0.00287	CcSEcCtD
Meprobamate—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.00188	0.00287	CcSEcCtD
Meprobamate—Dizziness—Raloxifene—osteoporosis	0.00188	0.00287	CcSEcCtD
Meprobamate—Vomiting—Estropipate—osteoporosis	0.00186	0.00285	CcSEcCtD
Meprobamate—Dizziness—Ibandronate—osteoporosis	0.00186	0.00284	CcSEcCtD
Meprobamate—Dermatitis—Estropipate—osteoporosis	0.00185	0.00282	CcSEcCtD
Meprobamate—Headache—Estropipate—osteoporosis	0.00184	0.00281	CcSEcCtD
Meprobamate—Vomiting—Alendronate—osteoporosis	0.00184	0.00281	CcSEcCtD
Meprobamate—Body temperature increased—Risedronate—osteoporosis	0.00183	0.0028	CcSEcCtD
Meprobamate—Dermatitis—Alendronate—osteoporosis	0.00182	0.00278	CcSEcCtD
Meprobamate—Hypotension—Conjugated Estrogens—osteoporosis	0.00181	0.00277	CcSEcCtD
Meprobamate—Headache—Alendronate—osteoporosis	0.00181	0.00277	CcSEcCtD
Meprobamate—Paraesthesia—Zoledronate—osteoporosis	0.00181	0.00276	CcSEcCtD
Meprobamate—Vomiting—Raloxifene—osteoporosis	0.00181	0.00276	CcSEcCtD
Meprobamate—Dermatitis—Raloxifene—osteoporosis	0.00179	0.00273	CcSEcCtD
Meprobamate—Somnolence—Zoledronate—osteoporosis	0.00179	0.00273	CcSEcCtD
Meprobamate—Vomiting—Ibandronate—osteoporosis	0.00179	0.00273	CcSEcCtD
Meprobamate—Headache—Raloxifene—osteoporosis	0.00178	0.00272	CcSEcCtD
Meprobamate—Dermatitis—Ibandronate—osteoporosis	0.00177	0.00271	CcSEcCtD
Meprobamate—Headache—Ibandronate—osteoporosis	0.00176	0.00269	CcSEcCtD
Meprobamate—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00175	0.00268	CcSEcCtD
Meprobamate—Vomiting—Calcitriol—osteoporosis	0.00175	0.00267	CcSEcCtD
Meprobamate—Agitation—Estradiol—osteoporosis	0.00175	0.00267	CcSEcCtD
Meprobamate—Nausea—Estropipate—osteoporosis	0.00174	0.00266	CcSEcCtD
Meprobamate—Body temperature increased—Pamidronate—osteoporosis	0.00174	0.00266	CcSEcCtD
Meprobamate—Paraesthesia—Conjugated Estrogens—osteoporosis	0.00174	0.00266	CcSEcCtD
Meprobamate—Angioedema—Estradiol—osteoporosis	0.00174	0.00265	CcSEcCtD
Meprobamate—Dermatitis—Calcitriol—osteoporosis	0.00173	0.00265	CcSEcCtD
Meprobamate—Headache—Calcitriol—osteoporosis	0.00172	0.00264	CcSEcCtD
Meprobamate—Somnolence—Conjugated Estrogens—osteoporosis	0.00172	0.00263	CcSEcCtD
Meprobamate—Nausea—Alendronate—osteoporosis	0.00172	0.00262	CcSEcCtD
Meprobamate—Hypersensitivity—Risedronate—osteoporosis	0.00171	0.00261	CcSEcCtD
Meprobamate—Vertigo—Estradiol—osteoporosis	0.00171	0.00261	CcSEcCtD
Meprobamate—Asthenia—Ethinyl Estradiol—osteoporosis	0.00171	0.00261	CcSEcCtD
Meprobamate—Syncope—Estradiol—osteoporosis	0.0017	0.0026	CcSEcCtD
Meprobamate—Nausea—Raloxifene—osteoporosis	0.00169	0.00258	CcSEcCtD
Meprobamate—Pruritus—Ethinyl Estradiol—osteoporosis	0.00168	0.00257	CcSEcCtD
Meprobamate—Palpitations—Estradiol—osteoporosis	0.00168	0.00257	CcSEcCtD
Meprobamate—Nausea—Ibandronate—osteoporosis	0.00167	0.00255	CcSEcCtD
Meprobamate—Loss of consciousness—Estradiol—osteoporosis	0.00167	0.00255	CcSEcCtD
Meprobamate—Asthenia—Risedronate—osteoporosis	0.00166	0.00254	CcSEcCtD
Meprobamate—Pruritus—Risedronate—osteoporosis	0.00164	0.00251	CcSEcCtD
Meprobamate—Nausea—Calcitriol—osteoporosis	0.00163	0.0025	CcSEcCtD
Meprobamate—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00163	0.00249	CcSEcCtD
Meprobamate—Hypersensitivity—Pamidronate—osteoporosis	0.00162	0.00248	CcSEcCtD
Meprobamate—Body temperature increased—Zoledronate—osteoporosis	0.00159	0.00243	CcSEcCtD
Meprobamate—Diarrhoea—Risedronate—osteoporosis	0.00159	0.00242	CcSEcCtD
Meprobamate—Asthenia—Pamidronate—osteoporosis	0.00158	0.00242	CcSEcCtD
Meprobamate—Dizziness—Ethinyl Estradiol—osteoporosis	0.00157	0.0024	CcSEcCtD
Meprobamate—Pruritus—Pamidronate—osteoporosis	0.00156	0.00238	CcSEcCtD
Meprobamate—Anaphylactic shock—Estradiol—osteoporosis	0.00155	0.00237	CcSEcCtD
Meprobamate—Dizziness—Risedronate—osteoporosis	0.00153	0.00234	CcSEcCtD
Meprobamate—Body temperature increased—Conjugated Estrogens—osteoporosis	0.00153	0.00234	CcSEcCtD
Meprobamate—Shock—Estradiol—osteoporosis	0.00153	0.00233	CcSEcCtD
Meprobamate—Tachycardia—Estradiol—osteoporosis	0.00151	0.00231	CcSEcCtD
Meprobamate—Vomiting—Ethinyl Estradiol—osteoporosis	0.00151	0.00231	CcSEcCtD
Meprobamate—Diarrhoea—Pamidronate—osteoporosis	0.00151	0.0023	CcSEcCtD
Meprobamate—Dermatitis—Ethinyl Estradiol—osteoporosis	0.0015	0.00229	CcSEcCtD
Meprobamate—Headache—Ethinyl Estradiol—osteoporosis	0.00149	0.00228	CcSEcCtD
Meprobamate—Hypersensitivity—Zoledronate—osteoporosis	0.00148	0.00227	CcSEcCtD
Meprobamate—Vomiting—Risedronate—osteoporosis	0.00147	0.00225	CcSEcCtD
Meprobamate—Dermatitis—Risedronate—osteoporosis	0.00146	0.00223	CcSEcCtD
Meprobamate—Dizziness—Pamidronate—osteoporosis	0.00146	0.00223	CcSEcCtD
Meprobamate—Headache—Risedronate—osteoporosis	0.00145	0.00222	CcSEcCtD
Meprobamate—Asthenia—Zoledronate—osteoporosis	0.00144	0.00221	CcSEcCtD
Meprobamate—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.00143	0.00218	CcSEcCtD
Meprobamate—Pruritus—Zoledronate—osteoporosis	0.00142	0.00218	CcSEcCtD
Meprobamate—Nausea—Ethinyl Estradiol—osteoporosis	0.00141	0.00216	CcSEcCtD
Meprobamate—Vomiting—Pamidronate—osteoporosis	0.0014	0.00214	CcSEcCtD
Meprobamate—Paraesthesia—Estradiol—osteoporosis	0.00139	0.00213	CcSEcCtD
Meprobamate—Asthenia—Conjugated Estrogens—osteoporosis	0.00139	0.00212	CcSEcCtD
Meprobamate—Dermatitis—Pamidronate—osteoporosis	0.00139	0.00212	CcSEcCtD
Meprobamate—Headache—Pamidronate—osteoporosis	0.00138	0.00211	CcSEcCtD
Meprobamate—Somnolence—Estradiol—osteoporosis	0.00138	0.00211	CcSEcCtD
Meprobamate—Diarrhoea—Zoledronate—osteoporosis	0.00138	0.0021	CcSEcCtD
Meprobamate—Nausea—Risedronate—osteoporosis	0.00138	0.0021	CcSEcCtD
Meprobamate—Pruritus—Conjugated Estrogens—osteoporosis	0.00137	0.0021	CcSEcCtD
Meprobamate—Dizziness—Zoledronate—osteoporosis	0.00133	0.00203	CcSEcCtD
Meprobamate—Diarrhoea—Conjugated Estrogens—osteoporosis	0.00133	0.00203	CcSEcCtD
Meprobamate—Nausea—Pamidronate—osteoporosis	0.00131	0.002	CcSEcCtD
Meprobamate—Dizziness—Conjugated Estrogens—osteoporosis	0.00128	0.00196	CcSEcCtD
Meprobamate—Vomiting—Zoledronate—osteoporosis	0.00128	0.00196	CcSEcCtD
Meprobamate—Dermatitis—Zoledronate—osteoporosis	0.00127	0.00194	CcSEcCtD
Meprobamate—Headache—Zoledronate—osteoporosis	0.00126	0.00193	CcSEcCtD
Meprobamate—Vomiting—Conjugated Estrogens—osteoporosis	0.00123	0.00188	CcSEcCtD
Meprobamate—Body temperature increased—Estradiol—osteoporosis	0.00123	0.00187	CcSEcCtD
Meprobamate—Dermatitis—Conjugated Estrogens—osteoporosis	0.00122	0.00187	CcSEcCtD
Meprobamate—Headache—Conjugated Estrogens—osteoporosis	0.00121	0.00186	CcSEcCtD
Meprobamate—Nausea—Zoledronate—osteoporosis	0.0012	0.00183	CcSEcCtD
Meprobamate—Nausea—Conjugated Estrogens—osteoporosis	0.00115	0.00176	CcSEcCtD
Meprobamate—Hypersensitivity—Estradiol—osteoporosis	0.00114	0.00175	CcSEcCtD
Meprobamate—Asthenia—Estradiol—osteoporosis	0.00111	0.0017	CcSEcCtD
Meprobamate—Pruritus—Estradiol—osteoporosis	0.0011	0.00168	CcSEcCtD
Meprobamate—Diarrhoea—Estradiol—osteoporosis	0.00106	0.00162	CcSEcCtD
Meprobamate—Dizziness—Estradiol—osteoporosis	0.00103	0.00157	CcSEcCtD
Meprobamate—Vomiting—Estradiol—osteoporosis	0.000986	0.00151	CcSEcCtD
Meprobamate—Dermatitis—Estradiol—osteoporosis	0.000977	0.00149	CcSEcCtD
Meprobamate—Headache—Estradiol—osteoporosis	0.000971	0.00148	CcSEcCtD
Meprobamate—Nausea—Estradiol—osteoporosis	0.000921	0.00141	CcSEcCtD
